CluenexHealthpeak Properties DOC
Healthpeak Properties scores weak on business quality (3.9 of 10). Here is why, in plain words, and what our sealed record shows.
Why it matters
- What Healthpeak Properties does
Healthpeak Properties owns and leases outpatient medical buildings and life science properties to healthcare providers and biotech tenants, generating rental revenue. The firm is preparing its third quarter 2026 earnings release and managing regular monthly dividend distributions.
- What it does best
Healthpeak commands a gross margin of 58.1%, outperforming peers like WELL at 40.3% and VTR at 40.2% due to specialized asset positioning in high-barrier medical clusters.
- The main risk
Interest coverage of 1.6x leaves the company highly vulnerable to debt servicing strains, especially with net debt sitting at $9.4 billion against trailing operating income.
Quality, check by check
Scored against its own industry, from company filings.
Operating margin of 17.9% and an ROE of 3.2% reflect thin bottom-line returns, indicating that scale does not rapidly expand profitability under heavy capital spending.
Specialized healthcare real estate creates moderate switching costs for medical tenants, placing gross margin in the bottom quartile at the 23rd sector percentile.
Revenue grew to $2.9 billion, representing a 4.6% growth rate that shows moderate expansion compared to historical multi-year figures.
Total debt of $9.8 billion and an interest coverage of 1.6x strain the balance sheet, while free cash flow sits at negative $650 million, signaling persistent capital burn.
Insiders
Executives and directors, from SEC Form 4 filings we read ourselves. Open market trades only; grants, option exercises and pre-planned sales left out.
No open market buys or unplanned sales by executives or directors.
Our sealed record on DOC
Verdicts appear here 30 days after we publish them; members see today's. Each one is in the nightly ledger, fingerprinted the night it was made.
The first sealed verdicts appear here on Oct 11, 2026.
Questions
Healthpeak Properties scores weak on the Cluenex quality check (3.9 of 10), measured against its own industry. Profitability is weak, moat fair, growth steady and financial health weak.
In the last 90 days of SEC Form 4 filings: No open market buys or unplanned sales by executives or directors.
Oct 21, 2026.
See DOC today
- Today's verdict on DOC, and why
- Fair value with cautious, base and optimistic cases
- The exact price that would change the verdict
- Which stocks each signal names, the night it fires
Cite this page: Cluenex, “Healthpeak Properties (DOC)”, https://cluenex.com/stocks/doc/, data as of Oct 10, 2026.